CA2922261A1 - Synthese et enrichissement de sequences d'acides nucleiques - Google Patents

Synthese et enrichissement de sequences d'acides nucleiques Download PDF

Info

Publication number
CA2922261A1
CA2922261A1 CA2922261A CA2922261A CA2922261A1 CA 2922261 A1 CA2922261 A1 CA 2922261A1 CA 2922261 A CA2922261 A CA 2922261A CA 2922261 A CA2922261 A CA 2922261A CA 2922261 A1 CA2922261 A1 CA 2922261A1
Authority
CA
Canada
Prior art keywords
sequence
reference
method
target
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2922261A
Other languages
English (en)
Inventor
Jason Poole
Saege HANCOCK
Karena Kosco
Vlada MELNIKOVA
Peter CROUCHER
Tim Lu
Mark G. Erlander
Errin SAMUELSZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trovagene Inc
Original Assignee
Trovagene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201361904141P priority Critical
Priority to US61/904,141 priority
Priority to US201462039905P priority
Priority to US62/039,905 priority
Application filed by Trovagene Inc filed Critical Trovagene Inc
Priority to US201461893283P priority
Priority to PCT/US2014/061435 priority patent/WO2015073163A2/fr
Priority to US61/893,283 priority
Publication of CA2922261A1 publication Critical patent/CA2922261A1/fr
Application status is Pending legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
CA2922261A 2013-10-20 2014-10-20 Synthese et enrichissement de sequences d'acides nucleiques Pending CA2922261A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US201361904141P true 2013-11-14 2013-11-14
US61/904,141 2013-11-14
US201462039905P true 2014-08-20 2014-08-20
US62/039,905 2014-08-20
US201461893283P true 2014-10-20 2014-10-20
PCT/US2014/061435 WO2015073163A2 (fr) 2013-11-14 2014-10-20 Synthese et enrichissement de sequences d'acides nucleiques
US61/893,283 2014-10-20

Publications (1)

Publication Number Publication Date
CA2922261A1 true CA2922261A1 (fr) 2015-05-21

Family

ID=53058234

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2922261A Pending CA2922261A1 (fr) 2013-10-20 2014-10-20 Synthese et enrichissement de sequences d'acides nucleiques

Country Status (2)

Country Link
CA (1) CA2922261A1 (fr)
WO (1) WO2015073163A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391592B1 (en) * 2000-12-14 2002-05-21 Affymetrix, Inc. Blocker-aided target amplification of nucleic acids
ES2547053T3 (es) * 2007-08-01 2015-10-01 Dana Farber Cancer Institute Enriquecimiento de una secuencia diana
AU2011224534B2 (en) * 2010-03-08 2014-10-09 Dana-Farber Cancer Institute, Inc. Full COLD-PCR enrichment with reference blocking sequence

Also Published As

Publication number Publication date
WO2015073163A2 (fr) 2015-05-21
WO2015073163A8 (fr) 2015-12-17
WO2015073163A3 (fr) 2015-11-05

Similar Documents

Publication Publication Date Title
Evrony et al. Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain
Chiu et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma
Underhill et al. Fragment length of circulating tumor DNA
Talens et al. Epigenetic variation during the adult lifespan: cross‐sectional and longitudinal data on monozygotic twin pairs
Van Beijsterveldt et al. The Young Netherlands Twin Register (YNTR): longitudinal twin and family studies in over 70,000 children
Zaina et al. DNA methylation map of human atherosclerosis
Martino et al. Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance
Fortin et al. Functional normalization of 450k methylation array data improves replication in large cancer studies
Chiu et al. Quantitative analysis of circulating mitochondrial DNA in plasma
Zhou et al. Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis
Lehmann-Werman et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA
Heitzer et al. Circulating tumor DNA as a liquid biopsy for cancer
Diaz Jr et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Feliubadaló et al. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes
Stessman et al. A genotype-first approach to defining the subtypes of a complex disease
Wallace et al. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa
San Lucas et al. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes
Kohlmann et al. The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories
Lo et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection
Hudecova Digital PCR analysis of circulating nucleic acids
Wilhelm et al. Implications of LINE1 methylation for bladder cancer risk in women
Capitain et al. The influence of fluorouracil outcome parameters on tolerance and efficacy in patients with advanced colorectal cancer
Heijmans et al. Commentary: The seven plagues of epigenetic epidemiology
Lurkin et al. Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes
Guttery et al. Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor–positive metastatic breast cancer